Elicio Therapeutics, Inc. — Form D

Elicio Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-27. The offering totals $12.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-01-27
• Form: D
• Accession: 0001601485-20-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $12.0M
• Amount sold: $1.0M
• Remaining: $11.0M
• Minimum investment: $65K
• Investors: 7
• Date of first sale: 2020-01-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-358981

Issuer

• Name: Elicio Therapeutics, Inc.
• CIK: 0001601485
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 451 D Street, Boston, MA, 02210
• Phone: (857) 209-0050

Officers, directors & promoters (24)

Other filings by this issuer (7)

More

• CIK 1601485 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search